340 results on '"Hung, Chien-Ching"'
Search Results
2. Mycoplasma genitalium infection and resistance-associated mutations to macrolides and fluoroquinolones among high-risk patients in Taiwan
3. Coexistent diffuse large B-cell lymphoma and disseminated Mycobacterium avium complex infection in a person with AIDS
4. Sexually transmitted coinfections among at-risk HIV-positive MSM: implications for optimal preemptive treatment
5. Under-utilization of statins among people with HIV who were aged 40 years or older
6. Polypharmacy and potential drug-drug interactions among people living with HIV in the era of integrase strand-transferase inhibitor-based antiretroviral therapy
7. Weight and metabolic changes among virally suppressed people with HIV who switched to co-formulated bictegravir/emtricitabine/tenofovir alafenamide
8. Epidemiology and risk factors of Japanese encephalitis in Taiwan, 2010–2022
9. Corrigendum to Evolution of estimated glomerular filtration rate in HIV/HCV-coinfected patients who received direct-acting antivirals: A multicenter retrospective study [J Microbiol Immunol Infect 56 (2023) 718–728]
10. Effectiveness of second-generation integrase strand-transfer inhibitor-based regimens for antiretroviral-experienced people with HIV who had viral rebound
11. Nontuberculous mycobacterial infection mimicking gynecologic malignancy in a woman living with HIV
12. Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial
13. HCV Microelimination for High-risk Special Populations
14. Higher Serologic Responses of Early Syphilis to Single-dose Benzathine Penicillin G Plus Doxycycline Versus Single-dose Benzathine Penicillin G Alone Among People With Human Immunodeficiency Virus (HIV)
15. Evolution of neutralizing antibodies and cross-activity against different variants of SARS-CoV-2 in patients recovering from COVID-19
16. Disseminated talaromycosis with presentations of painful oral ulcers and generalized papules in a 44-year-old man with advanced HIV infection
17. Durability of serologic responses to inactivated hepatitis A virus vaccination among people living with HIV following acute hepatitis A outbreak: a 5-year follow-up study
18. Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial
19. Entamoeba histolytica (Amebiasis)
20. List of Contributors
21. Prevalence, Associated Factors, and Appropriateness of Empirical Treatment of Trichomoniasis, Bacterial Vaginosis, and Vulvovaginal Candidiasis among Women with Vaginitis
22. Immune Reconstitution Inflammatory Syndrome in People Living with HIV Who Presented with Interstitial Pneumonitis: an Emerging Challenge in the Era of Rapid Initiation of Antiretroviral Therapy
23. A randomized clinical trial of one-dose versus accelerated two-dose schedule for hepatitis A virus revaccination among people with HIV who were non-responders or had seroreversion after primary HAV vaccination
24. Preventing 2 viral infections with 1 tablet
25. Evolution of estimated glomerular filtration rate in HIV/HCV-coinfected patients who received direct-acting antivirals: A multicenter retrospective study
26. Factors associated with viral rebound among COVID-19 patients receiving oral antivirals
27. Epidemiology, clinical features, and outcomes of strongyloidiasis in Taiwan from 1988 to 2020: A case series and literature review
28. Coexistent disseminated Kaposi's sarcoma and disseminated Mycobacterium avium complex infection in a patient with AIDS
29. Patient-reported outcomes among virally suppressed people living with HIV after switching to Co-formulated bictegravir, emtricitabine and tenofovir alafenamide
30. Risky sexual practices and hepatitis C viremia among HIV-positive men who have sex with men in Taiwan
31. Switching to coformulated bictegravir, emtricitabine, and tenofovir alafenamide maintained viral suppression in adults with historical virological failures and K65N/R mutation
32. Impact of the initial wave of COVID-19 pandemic in Taiwan on local HIV services: Results from a cross-sectional online survey
33. Impact of coronavirus disease 2019 on the HIV testing and health care delivery at a university hospital in Taiwan, 2020–2021
34. Evolution of anti-SARS-CoV-2 spike protein titers after two-dose of COVID-19 vaccination among people living with HIV
35. Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan
36. Virological responses to tenofovir-alafenamide-containing antiretroviral therapy in people living with HIV co-infected with lamivudine-resistant or lamivudine-susceptible hepatitis B virus
37. Same‐dayand rapid initiation of antiretroviral therapy in people living withHIVin Asia. How far have we come?
38. Pyrazinamide related prolonged drug-induced liver injury: A case report
39. Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimens
40. Disseminated Mycobacterium chimaera infection in a patient with adult-onset immunodeficiency syndrome: case report
41. Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study
42. Impact of COVID-19 on the HIV care continuum in Asia: Insights from people living with HIV, key populations, and HIV healthcare providers
43. Three-Stage Pooled Plasma Hepatitis C Virus RNA Testing for the Identification of Acute HCV Infections in At-Risk Populations
44. Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk Populations
45. Hepatitis C microelimination among people living with HIV in Taiwan
46. Incidence of low-level viremia and its impact on virologic failure among people living with HIV-1 who switched to elvitegravir-based antiretroviral therapy
47. Effectiveness of COVID-19 vaccination among people living with HIV during a COVID-19 outbreak
48. Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression
49. Sexually-transmitted hepatitis C virus reinfections among people living with HIV in Taiwan: the emerging role of genotype 6
50. Accelerated progression of pulmonary tuberculosis in a COVID-19 patient after corticosteroid treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.